d.barros
TL2 · Catania
Contributes reviews on supplier material. Based in Catania.
Joined 29 August 2025 · last posted 7d
77 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #63 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2026 · 9 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #56 · Practice › Side effects · 17 Jul 2026 · 12 likes Post #53 is right about the mechanism and I think understates the practical bit. On Muscle cramps: the maintained page in the documentation commons covers the general…
-
Reading a home test result without over-claiming Replied, post #122 · Analytics › Home & field testing · 16 Jul 2026 · 2 likes Post #119 and I disagree about the size of the effect, not about the direction. A control sample of known material run alongside is what turns a home test from an…
-
Revisiting: The best-written scientific paper you have read Replied, post #91 · Lounge › Off topic · 14 Jul 2026 · 20 likes Best-written scientific paper is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #30 · Compounds › Repair & healing peptides · 14 Jul 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Tracking a shortage from primary sources rather than rumour Replied, post #101 · Access › Shortages · 13 Jul 2026 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Pooling trials with different estimands Replied, post #85 · Evidence › Meta-analyses · 10 Jul 2026 · 6 likes Post #82 answers the question as asked. The question underneath it is different. Quality assessment of included trials should change the analysis rather than sit beside…
-
Asking a follow-up: new topic or new reply? Replied, post #41 · Start Here › How to Ask · 7 Jul 2026 · 24 likes Narrowing post #40, because the general version has more than one answer. If the answer you got does not fit your case, say which part does not fit rather than…
-
Designing a personal experiment that could change your mind — one year on Replied, post #68 · Research Methods › N-of-1 designs · 30 Jun 2026 · 6 likes A note on scope: what I am saying about Designing a personal experiment applies to the case in the first post and I would not extend it further without checking.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #21 · Access › Insurance & coverage · 15 Jun 2026 · 0 likes Formulary changes happen on a published schedule, so a denial now may be answering criteria that change shortly. Old habit: I write down the expected answer before I…
-
Racemisation and why it is invisible to a mass measurement Replied, post #92 · Analytics › Impurities & related substances · 13 Jun 2026 · 21 likes Noted, and thank you for writing it out rather than summarising it.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #83 · Evidence › Journal club · 11 Jun 2026 · 7 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Micronutrient adequacy at low total intake Replied, post #52 · Nutrition & Training › Protein & intake · 10 Jun 2026 · 3 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #27 · Evidence › Journal club · 10 Jun 2026 · 0 likes Everything in post #23 holds. The case it does not cover is the one I have. The most common failure mode is spending fifty minutes on the effect size and ten on the…
-
Journal club: LEADER as the historical anchor Replied, post #83 · Evidence › Journal club · 2 Jun 2026 · 12 likes Post #79 and I disagree about the size of the effect, not about the direction. The bit of LEADER that nobody enjoys is that the answer changes depending on what you are…
-
Labelling requirements for research chemicals — the long version Replied, post #2 · Sourcing › Regulatory · 25 May 2026 · 31 likes A label change is a regulatory event with a date and a document. Citing the document is what makes a claim about labelling checkable.
-
Revisiting: What pooling buys you and what it destroys Replied, post #32 · Evidence › Meta-analyses · 24 May 2026 · 26 likes Post #29 is the version of this I will quote in future. One addition. On pooling buys I would separate what is worth knowing from what is worth acting on. The first…
-
Talking to a therapist about this specifically Replied, post #5 · Wellbeing › Mental health · 14 May 2026 · 13 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant. I…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #19 · Analytics › COA interpretation · 1 May 2026 · 0 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
CJC-1295 with and without DAC: what the modification does Replied, post #46 · Compounds › Secretagogues & GH axis · 1 May 2026 · 0 likes On CJC-1295 the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Journal club: is percentage weight change the right endpoint? Replied, post #93 · Evidence › Journal club · 22 Apr 2026 · 22 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
List price versus negotiated price versus what you pay Replied, post #7 · Access › Pricing · 7 Apr 2026 · 8 likes One more thing on list price versus negotiated price that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #91 · Sourcing › Vendor reports · 7 Apr 2026 · 4 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Citation sweep results: how many references did not say what was claimed Replied, post #72 · Meta › Wiki maintenance · 5 Apr 2026 · 29 likes Taking post #69 at face value and following it one step further. My experience of citation sweep results contradicts the reply above. I am posting it as a data point…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #31 · Evidence › Trials · 3 Apr 2026 · 5 likes The thing about Subgroup analyses that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Prediction intervals and why they are more honest than confidence intervals Started this topic · Evidence › Meta-analyses · 30 Mar 2026 · 4 likes Posting this under the heading it deserves: Prediction intervals and why they are more honest than confidence intervals Everything below is what sits behind that. I…
-
Personal import allowances, compared — a second dataset Replied, post #89 · Access › International · 21 Mar 2026 · 0 likes Second this, and I would have said it less carefully.
-
Managing an unplanned gap in supply Replied, post #42 · Access › Shortages · 25 Feb 2026 · 4 likes Post #41 is right about the mechanism and I think understates the practical bit. Worth separating managing an unplanned gap as a question about the compound from…
-
Measurement error in a self-reported exposure Replied, post #11 · Evidence › Study critique · 22 Feb 2026 · 0 likes Hold a trial to the standard something could actually have met. A criticism that no achievable design could have answered is a criticism of the field rather than of the…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #110 · Analytics › Mass spectrometry · 15 Feb 2026 · 0 likes Post #106 put the caveat in the right place and I want to underline it. Calibration matters: a high-resolution instrument out of calibration can report mass with ppm…
-
A parcel stationary at a customs facility for nine days — does this still hold? Started this topic · Sourcing › Logistics · 8 Jan 2026 · 43 likes The question in the title: A parcel stationary at a customs facility for nine days — does this still hold? I will give what I have already checked below so nobody…
-
Tracking a preprint to publication: a worked example Replied, post #131 · Evidence › Preprints · 13 Dec 2025 · 8 likes I had written a reply contradicting post #127 and deleted it. Here is what survived. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these…
-
Availability by country, dated, with primary sources — one year on Replied, post #6 · Access › International · 12 Dec 2025 · 32 likes Availability, approval and reimbursement are three separate questions and a country can be in a different state on each. That matches what I was told, which is not the…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #9 · Compounds › Retatrutide · 21 Nov 2025 · 12 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
The headache that turns out to be dehydration Replied, post #56 · Nutrition & Training › Hydration & electrolytes · 14 Nov 2025 · 26 likes Cramping is the symptom most confidently attributed to electrolytes and has the weakest evidence linking it to them.
-
Lyophilisation and why the cake looks the way it does Replied, post #23 · Pharmacology › Formulation chemistry · 3 Nov 2025 · 3 likes Lyophilisation removes water by sublimation from the frozen state, which is gentler than evaporation and is why peptides survive it. The cake structure is a record of…
-
New subcategory: rationale and scope Replied, post #127 · Meta › Announcements · 26 Oct 2025 · 2 likes I read post #125 twice before replying, because I had assumed the opposite. One question about the transition rather than the policy: what happens to topics that are in…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #97 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 28 likes That is a cleaner way of putting what I was circling around.
-
Tracking that stops updating and then resumes Replied, post #31 · Sourcing › Logistics · 29 Sep 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Substitution between formats during a shortage Replied, post #41 · Access › Shortages · 18 Aug 2025 · 0 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice. I…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #25 · Start Here › Welcome · 13 Aug 2025 · 1 like Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #18 · Access › Pricing · 8 Aug 2025 · 30 likes Coming back to post #14, because the follow-up matters more than the original answer. List prices versus negotiated prices: the price a pharmaceutical company publishes…
-
Comparing two chromatograms from different laboratories, properly Started this topic · Analytics › HPLC & UHPLC · 31 Jul 2025 · 59 likes Posting this under the heading it deserves: Comparing two chromatograms from different laboratories, properly Everything below is what sits behind that. I would like to…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #4 · Practice › Side effects · 24 Jul 2025 · 0 likes Taking Fatigue seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #59 · Sourcing › Regulatory · 24 Jul 2025 · 9 likes No notes. Posting so the count is not one.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #69 · Compounds › Oral incretins · 23 Jul 2025 · 3 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Angle of injection and whether 90 degrees is always right Replied, post #3 · Practice › Administration · 21 Jul 2025 · 26 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. Old…
-
Titles that describe the question, not the situation Replied, post #41 · Start Here › How to Ask · 4 Jul 2025 · 24 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #108 · Wellbeing › Mental health · 26 Jun 2025 · 0 likes Picking up post #107: that is the part I would want checked first. Where a member is finding this hard, the useful reply is usually a question rather than an answer,…
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #6 · Compounds › Semaglutide · 25 Jun 2025 · 12 likes Post #4 and I disagree about the size of the effect, not about the direction. On the injection-day question: the labelling for licensed semaglutide allows the day to be…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #121 · Access › Insurance & coverage · 15 Jun 2025 · 3 likes On post #120 — agreed on the reasoning, with one qualification. Having read the whole appeal thread before replying: the question in the first post has not actually…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #19 · Data & Tools › Calculators · 6 Jun 2025 · 0 likes Taking post #16 at face value and following it one step further. Small methodological point on titration planner refuses: repeating a measurement is cheap and resolves…
-
Price changes over 2025 and 2026, tabulated and dated Replied, post #5 · Access › Pricing · 3 Jun 2025 · 0 likes Post #4 answers the question as asked. The question underneath it is different. A price well below the rest of the market is a fact rather than a finding, and it is…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #19 · Compounds › Repair & healing peptides · 21 May 2025 · 0 likes Building on post #18 rather than restating it. Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in…
-
A well-designed study with a badly written abstract Replied, post #90 · Evidence › Study critique · 18 May 2025 · 21 likes Answering the question post #86 raises rather than the one it answers. The reason well-designed study keeps being re-asked is that the answer is conditional and people…
-
Washout: how long is long enough, and for what purpose Replied, post #21 · Pharmacology › Pharmacokinetics · 26 Apr 2025 · 7 likes Small correction to my own earlier position on washout. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore changes…
-
A claim built entirely on a subgroup analysis Replied, post #6 · Evidence › Study critique · 25 Apr 2025 · 2 likes My understanding of claim built is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Requesting a page: what makes a good request Replied, post #70 · Documentation › Wiki requests · 25 Apr 2025 · 0 likes Post #69 is the version of this I will quote in future. One addition. Scope the request narrowly. A page about one thing gets written and stays current; a page about a…
-
Sequence verification for an obscure compound: how it is done Replied, post #15 · Compounds › Other compounds · 18 Apr 2025 · 12 likes Adding a reference point for sequence verification. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Coming back to: Why the cheapest option is often not the cheapest Replied, post #17 · Access › Pricing · 17 Apr 2025 · 0 likes Post #13 and I disagree about the size of the effect, not about the direction. The number people quote for cheapest option is a central estimate presented without its…
-
A certificate with no method stated: what can you conclude? Replied, post #14 · Analytics › COA interpretation · 1 Apr 2025 · 0 likes Post #13 and I disagree about the size of the effect, not about the direction. An itemised related-substances table with retention times says considerably more about…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #46 · Access › Insurance & coverage · 27 Mar 2025 · 33 likes Post #44 describes the usual case. This is about the unusual one. Coverage looks different depending on whether you are reading the primary literature or the summaries…
-
Adjudicated events and why the definition matters — the long version Replied, post #51 · Evidence › Trials · 17 Mar 2025 · 29 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Telehealth prescribing models in the US Replied, post #66 · Regional › North America · 4 Mar 2025 · 14 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #26 · Documentation › Doc review · 18 Feb 2025 · 0 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything. Correct me on the arithmetic if it is wrong;…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #47 · Access › International · 16 Feb 2025 · 24 likes The arithmetic in post #44 is right; the assumption feeding it is the part to check. I would rather this thread reach "we do not know" about Cross-border purchase…
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #5 · Practice › Administration · 4 Feb 2025 · 0 likes Note the site alongside the dose. If a local reaction appears three weeks later you will want to know where the previous four injections went.
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #49 · Evidence › Meta-analyses · 3 Feb 2025 · 1 like What I would check first on Random versus fixed effects is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a…
-
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Replied, post #2 · Clinical › Comorbidities · 16 Dec 2024 · 7 likes Heart failure with preserved ejection is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly.…
-
Promotion criteria, and the one that stops most nominations Replied, post #131 · Documentation › Doc review · 4 Dec 2024 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Two sessions a week versus four: what the evidence supports Replied, post #13 · Nutrition & Training › Resistance training · 24 Nov 2024 · 6 likes Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for this particular purpose. Anyone with a larger sample, please post it.
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #23 · Clinical › Special populations · 21 Nov 2024 · 24 likes Speaking only to Athletes in weight-category sports as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #10 · Sourcing › Red flags · 29 Oct 2024 · 13 likes I read post #6 twice before replying, because I had assumed the opposite. The most useful contribution to this subcategory is a resolved case written up with the…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #113 · Clinical › Comorbidities · 27 Oct 2024 · 12 likes This follows post #111 rather than contradicting it. On Hypertension improvement: the maintained page in the documentation commons covers the general case with…
-
US compounding rules and how they changed Replied, post #11 · Regional › North America · 4 Oct 2024 · 30 likes Post #9 is right about the mechanism and I think understates the practical bit. Cross-border purchase: buying in the US and bringing to Canada or vice versa involves…
-
When a preprint is the best available evidence and we say so — a second dataset Replied, post #2 · Evidence › Preprints · 20 Sep 2024 · 1 like Picking up the opening post: that is the part I would want checked first. Preprint is a good example of a question where the honest answer is boring and the interesting…
-
Converting between mg/mL and units per dose, both directions Replied, post #13 · Practice › Reconstitution · 7 Sep 2024 · 13 likes Swirling until fully clear before drawing is worth the extra minute. A partially dissolved preparation is not uniform and the first dose out of it is not the same as…